Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 18/09/2026			5-day change	1st Jan Change
12.39 ^MXN	-1.43%		-1.98%	-30.74%

09-17	Genomma Lab Internacional, S.A.B. de C.V. Announces CEO Changes	CI
09-01	Genomma Lab Internacional, S.A.B. de C.V. Enters Into MXN 1.0 Billion Long-Term Credit Facility With Banamex	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	12,081	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-30.86%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	16,271	15,746	15,313
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-26.84%	-3.23%	-2.75%
P/E	14.9x	12x	13.1x	11.7x	11.1x	6.55x	6.27x	5.62x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	0.86x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.4x	1.44x	0.5x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.67x	0.64x	0.61x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	0.9x	0.84x	0.77x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	3.98x	3.68x	3.36x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.36x	4.05x	3.69x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	11.3x	7.91x	7.13x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	8.84%	12.6%	14%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8003	1.071	1.441
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	6.46%	8.65%	11.6%
EPS ²	1.44	1.41	1.08	2.14	1.61	1.893	1.975	2.206
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	42.3%	54.2%	65.3%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	17,991	18,740	19,945
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,090	4,279	4,559
EBIT ¹	3,063	3,263	3,224	3,982	3,760	3,733	3,886	4,146
Net income ¹	1,451	1,397	1,031	2,137	1,607	1,906	2,058	2,285
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,190	3,666	3,233
Reference price ²	21.48	16.94	14.16	25.13	17.89	12.39	12.39	12.39
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	975,033	-	-
Announcement Date	2/23/22 A	2/22/23 A	2/21/24 A	2/26/25 A	2/25/26 A	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	6.55x	0.9x	3.98x	6.46%	700M
ELI LILLY AND COMPANY	32.78x	11.92x	24.16x	0.6%	1,028B
JOHNSON & JOHNSON	30.03x	6.68x	18.7x	1.99%	651B
ABBVIE INC.	33.38x	7.81x	16.15x	2.6%	466B
ROCHE HOLDING AG	19.33x	4.72x	11.71x	2.81%	346B
NOVARTIS AG	19.72x	5.16x	12.79x	3.11%	266B
ASTRAZENECA PLC	21.26x	4.42x	12.58x	1.99%	259B
AMGEN INC.	24.43x	6.42x	11.43x	2.62%	208B
NOVO NORDISK A/S	12.52x	4.56x	9.46x	4.01%	191B
GILEAD SCIENCES, INC.	-45.4x	6.61x	25.81x	2.19%	186B
Average	15.46x	5.92x	14.68x	2.84%	360.24B
Weighted average by Cap.	23.67x	7.72x	17.83x	1.99%